ADAMTSL3 as a candidate gene for schizophrenia: gene sequencing and ultra-high density association analysis by

David J Dow1, Julie Huxley-Jones, Jamie M Hall

  • 1Molecular Discovery Research, GlaxoSmithKline Pharmaceuticals, New Frontiers Science Park (North), Third Avenue, Harlow, CM19 5AW, UK. David.J.Dow@gsk.com

Schizophrenia Research
|January 18, 2011
PubMed